TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23025736

Group type: EXPERIMENTAL
Intervention: Nurse-GP partnership intervention
Number of subjects: 451

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 451
Study: 20008425

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 18082676

Group type: EXPERIMENTAL
Intervention: Human infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cotton-top tamarin monkeys
Number of subjects: 0
Study: 16601504

Group type: EXPERIMENTAL
Intervention: Home-visiting programs by professionals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 12950328

Group type: EXPERIMENTAL
Intervention: Transdermal oestrogen replacement therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Not applicable (placebo control)
Number of subjects: 71
Study: 11126150

Group type: EXPERIMENTAL
Intervention: Bladder-sphincter-biofeedback training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Pelvic floor exercise
Number of subjects: 31
Study: 8823677

Group type: EXPERIMENTAL
Intervention: Electronic timing device to measure drive phase time
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Electronic timing device to measure recovery phase time
Number of subjects: 17
Study: 1442656

Group type: EXPERIMENTAL
Intervention: 50-mg/d iron supplement and a low food-iron diet (50 FE + EX)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 10-mg/d iron supplement and a low food-iron diet (10 FE + EX)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Placebo and unrestricted diet (P + EX)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Meat supplement and high food-iron diet (M + EX)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sedentary control group (n = 13)
Number of subjects: 47
Study: 6535823

Group type: EXPERIMENTAL
Intervention: Medial epicondylectomy and external decompression with steroid therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Steroid therapy alone
Number of subjects: 44
Study: 31208376

Group type: EXPERIMENTAL
Intervention: Smartphone app and TAU (treatment as usual)
Number of subjects: 260

Group type: COMPARATOR
Intervention: TAU without the smartphone app
Number of subjects: 260
Study: 30279091

Group type: EXPERIMENTAL
Intervention: Personalised letter
Number of subjects: 5534

Group type: EXPERIMENTAL
Intervention: Pamphlet
Number of subjects: 5534

Group type: COMPARATOR
Intervention: Control (no direct communication)
Number of subjects: 5534
Study: 27240158

Group type: EXPERIMENTAL
Intervention: Energy drink
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Panax ginseng
Number of subjects: 0
Study: 24768633

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) injection of anthrax vaccine adsorbed (AVA)
Number of subjects: 1563

Group type: COMPARATOR
Intervention: Intramuscular (IM) injection of anthrax vaccine adsorbed (AVA)
Number of subjects: 1563

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) injection of anthrax vaccine adsorbed (AVA) in obese participants
Number of subjects: 1563

Group type: EXPERIMENTAL
Intervention: Female participants receiving AVA
Number of subjects: 1563

Group type: EXPERIMENTAL
Intervention: Participants with highest anti-PA IgG concentrations
Number of subjects: 1563

Group type: EXPERIMENTAL
Intervention: Black participants receiving AVA
Number of subjects: 1563

Group type: EXPERIMENTAL
Intervention: Women-only subset analysis
Number of subjects: 1563
Study: 22503739

Group type: EXPERIMENTAL
Intervention: Tailored multifactorial falls prevention program
Number of subjects: 156

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 156
Study: 20466657

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) - two doses at 15 mg/kg to a maximum of 750 mg per dose
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Venofer(R) - 1000 mg administered as five infusions of 200 mg
Number of subjects: 2500
Study: 18155993

Group type: EXPERIMENTAL
Intervention: Restricted-carbohydrate diets
Number of subjects: 13
Study: 16362853

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary angioplasty (PTCA)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Surgical coronary artery bypass grafting (CABG)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (CABG in younger patients)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Overall outcomes for octogenarians
Number of subjects: 63

Group type: COMPARATOR
Intervention: Overall outcomes for younger patients
Number of subjects: 63
Study: 12431318

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10226853

Group type: EXPERIMENTAL
Intervention: Transdermal NTG (0.6 mg/h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sublingual NTG after 5 days of sustained transdermal NTG therapy (0.6 mg/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral vitamin C (2 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8902425

Group type: EXPERIMENTAL
Intervention: High-voltage galvanic stimulation of ST36 and ST37 acupuncture points
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 11
Study: 1860385

Group type: EXPERIMENTAL
Intervention: L-tryptophan 3.0g/day for six weeks
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 6617066

Group type: EXPERIMENTAL
Intervention: Amiloride (median dosage 15 mg/day or 5 mg per 25 mg hydrochlorothiazide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (continued therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiloride (adjunctive treatment)
Number of subjects: 0
Study: 31229396

Group type: EXPERIMENTAL
Intervention: 6-session, 6-month director's child nutrition course with on-site technical support for center teachers
Number of subjects: 408

Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 408
Study: 28484877

Group type: EXPERIMENTAL
Intervention: Two NSAIDs (diclofenac and celecoxib) with morphine sulfate 10 mg/12 h
Number of subjects: 342

Group type: COMPARATOR
Intervention: Diclofenac with morphine sulfate 10 mg/12 h
Number of subjects: 342

Group type: COMPARATOR
Intervention: Celecoxib with morphine sulfate 10 mg/12 h
Number of subjects: 342
Study: 26388272

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg etomidate IV (Group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg etomidate IV following 2 mg/kg methylprednisolone IV (Group II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg IV midazolam (Group III)
Number of subjects: 60
Study: 24279592

Group type: EXPERIMENTAL
Intervention: TEA (TEA plus standard care)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 40
Study: 21127883

Group type: EXPERIMENTAL
Intervention: Intravenous glutathione (GSH) 100 mg/min for 30 min before CAG
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intravenous glutathione (GSH)
Number of subjects: 21
Study: 19843054

Group type: EXPERIMENTAL
Intervention: HP‐beta‐CD formulation at 1, 10, 30 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HP‐beta‐CD formulation at 100 microg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Tween formulation at 100 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 16
Study: 17928994

Group type: EXPERIMENTAL
Intervention: Strict glucose control group (SGC) with a blood glucose target of 4-6 mmol/l
Number of subjects: 90

Group type: COMPARATOR
Intervention: Moderate glucose control group (MGC) with a blood glucose target of 6-8 mmol/l
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mortality by day 30
Number of subjects: 90
Study: 15011890

Group type: EXPERIMENTAL
Intervention: Eradication therapy (omeprazole, amoxicillin, and clarithromycin)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 50
Study: 11724204

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Verapamil (240 mg)
Number of subjects: 145
Study: 9425876

Group type: EXPERIMENTAL
Intervention: Generic Valproic Acid USP (Solvay)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Depakene
Number of subjects: 64
Study: 8488960

Group type: EXPERIMENTAL
Intervention: 0.015-0.025 mg/kg haloperidol
Number of subjects: 16

Group type: COMPARATOR
Intervention: 2 ml normal saline (control)
Number of subjects: 16
Study: 3318435

Group type: EXPERIMENTAL
Intervention: Nabumetone (1,000 mg at bedtime)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naproxen (250 mg twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 40
Study: 29345541

Group type: EXPERIMENTAL
Intervention: Handheld full water bottle (FULL; 16.9 fluid oz; 454 g)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Handheld half-full water bottle (HALF; 8.4 fluid oz; 227 g)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Waist-worn bottle belt holder (BELT; hydration belt; 676 g)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control run (CON)
Number of subjects: 42
Study: 25849068

Group type: EXPERIMENTAL
Intervention: Wingate test (WT) with 8.7% of body mass (BM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Wingate test (WT) with 11% of body mass (BM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Force-Velocity test (FVT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Wingate test (WT)
Number of subjects: 20
Study: 25887136

Group type: EXPERIMENTAL
Intervention: BT086 (IgM-enriched immunoglobulin preparation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care treatment
Number of subjects: 0
Study: 24006952

Group type: EXPERIMENTAL
Intervention: Goldmann tonometer (GAT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Icare PRO (ICP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tono-Pen AVIA (TPA)
Number of subjects: 36
Study: 21586215

Group type: EXPERIMENTAL
Intervention: Adaptive oral hygiene devices and orofacial exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual dental care (manual toothbrush and dental floss)
Number of subjects: 48
Study: 18508140

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (not explicitly mentioned as control)
Number of subjects: 415
Study: 17942271

Group type: EXPERIMENTAL
Intervention: Hypothetical breast cancer risk above average
Number of subjects: 249
Study: 15234486

Group type: EXPERIMENTAL
Intervention: Functional instability of the ankle joint
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study: 11566651

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched formula (EF)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Breast-fed
Number of subjects: 474

Group type: COMPARATOR
Intervention: Standard term formula (TF)
Number of subjects: 474
Study: 9597051

Group type: EXPERIMENTAL
Intervention: 3-minute scripted informational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uninformed patients
Number of subjects: 0
Study: 7750407

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg + PG05 1 mg on the 3rd or 4th day
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 25 mg b.i.d. (total amount of 150mg) + PG05 1mg on the 3rd or 4th day
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 25 mg b.i.d. (total amount of 125mg) + PG05 1mg in the morning of the 3rd day
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 200mg + misoprostol 600 micrograms on the 3rd day
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 150mg + misoprostol 600 micrograms on the 3rd day
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg immediately, then 25 mg b.i.d. (total amount of 150mg) + misoprostol 600 micrograms
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg in the morning and 25mg in the evening for two days (total amount of 150 mg) + misoprostol 600 micrograms
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Mifepristone 25 mg b.i.d. (total amount of 125mg) + misoprostol 400 micrograms
Number of subjects: 1035
Study: 2223363

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 300 ml h‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 600 ml h‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 1200 ml h‐1
Number of subjects: 60
Study: 345827

Group type: EXPERIMENTAL
Intervention: Vitamin B6 (pyridoxine)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 16
Study: 31524502

Group type: EXPERIMENTAL
Intervention: Taichi exercise for 24 weeks
Number of subjects: 92

Group type: COMPARATOR
Intervention: Health education lectures (Control)
Number of subjects: 92
Study: 30957736

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Present-Centred Therapy (PCT)
Number of subjects: 33
Study: 28731611

Group type: EXPERIMENTAL
Intervention: Caffeinated energy drink consumption
Number of subjects: 919

Group type: COMPARATOR
Intervention: Normal sleep patterns
Number of subjects: 919
Study: 25710288

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Pre-ART height-for-age Z-score
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Pre-ART BMI-for-age in girls
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Tanner stage 5
Number of subjects: 582
Study: 26658902

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 132

Group type: COMPARATOR
Intervention: PCV10
Number of subjects: 132
Study: 23895801

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (target dose 15-20 mg/wk)
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7000
Study: 21649614

Group type: EXPERIMENTAL
Intervention: PTSD symptoms (endorsed by 12% of participants, 2,041/17,205)
Number of subjects: 17205

Group type: EXPERIMENTAL
Intervention: PTSD all clusters
Number of subjects: 17205

Group type: EXPERIMENTAL
Intervention: Partial PTSD
Number of subjects: 17205

Group type: COMPARATOR
Intervention: No trauma history or trauma but no symptoms
Number of subjects: 17205
Study: 19032751

Group type: EXPERIMENTAL
Intervention: Adapted Physical Activity program for flexed posture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-specific physical activity protocol for the elderly
Number of subjects: 0
Study: 16244087

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 microg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) strategy
Number of subjects: 0
Study: 15013268

Group type: EXPERIMENTAL
Intervention: Clopidogrel pretreatment (300 mg loading dose 24 hours before PCI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No clopidogrel pretreatment (control group)
Number of subjects: 20
Study: 10764368

Group type: EXPERIMENTAL
Intervention: Nurse telephone consultation
Number of subjects: 97000
Study: 10374272

Group type: EXPERIMENTAL
Intervention: Nitrendipine treatment group
Number of subjects: 3064

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3064
Study: 7939508

Group type: EXPERIMENTAL
Intervention: Heparin-coated CPB circuit with a 50% reduction of the standard heparin dose
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard CPB circuit with a standard heparin dose (300 IU/kg)
Number of subjects: 19
Study: 3064861

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) administered to 188 patients
Number of subjects: 376

Group type: COMPARATOR
Intervention: Radical radiotherapy (64 Gy) or pre-operative radiotherapy (44 Gy)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: MTX + radiotherapy
Number of subjects: 376

Group type: COMPARATOR
Intervention: Radical radiotherapy
Number of subjects: 376
Study: 29458335

Group type: EXPERIMENTAL
Intervention: Integrated children's care clinic (ICCC)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Self-directed care pathway
Number of subjects: 112
Study: 26920669

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided forearm block with saline placebo wrist block
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional landmark-based wrist block with saline placebo ultrasound-guided forearm block
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided forearm block
Number of subjects: 12
Study: 25764615

Group type: EXPERIMENTAL
Intervention: McGrath series 5 videolaryngoscope (MGL)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 22
Study: 23444203

Group type: EXPERIMENTAL
Intervention: Apical Negative Pressure (ANP) irrigation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Positive Pressure (PP) irrigation
Number of subjects: 32
Study: 20059360

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic euglycemic clamp (80 mU/m(2) per min)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Hyperglycemic clamp
Number of subjects: 33
Study: 18173766

Group type: EXPERIMENTAL
Intervention: Intralesional clostridial collagenase injection therapy (10,000 units, 0.25 cm³ per injection, administered over 7-10 days, with a repeat treatment at 3 months)
Number of subjects: 25
Study: 16423441

Group type: EXPERIMENTAL
Intervention: Real patient assessments with radiographic information
Number of subjects: 201

Group type: COMPARATOR
Intervention: Paper patient assessments without radiographic information
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Group 2 clinical assessment
Number of subjects: 201

Group type: COMPARATOR
Intervention: Group 4 clinical assessment
Number of subjects: 201
Study: 14699304

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg) and 600 mg calcium per day for 2 years
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo and 600 mg calcium per day for 2 years
Number of subjects: 38
Study: 11038976

Group type: EXPERIMENTAL
Intervention: Modified recipe of Wang Kentang's Bai Fu Ling Wan
Number of subjects: 32

Group type: COMPARATOR
Intervention: Capoton (control group)
Number of subjects: 32
Study: 8837183

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA) with 3 mL of hyperbaric 0.5% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General Anesthesia (GA) maintained with isoflurane and nitrous oxide
Number of subjects: 60

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 60
Study: 7840600

Group type: EXPERIMENTAL
Intervention: 400 mg of ofloxacin
Number of subjects: 10

Group type: COMPARATOR
Intervention: 400 mg of ofloxacin plus 11 g of colloidal aluminum phosphate
Number of subjects: 10
Study: 3224543

Group type: EXPERIMENTAL
Intervention: Mutual decision making
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Didactic
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Authoritarian
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study: 29246848

Group type: EXPERIMENTAL
Intervention: Surgical treatment for IDH
Number of subjects: 803
Study: 26129915

Group type: EXPERIMENTAL
Intervention: Repeated bout group (N=16) performed 2 bouts of sport-specific sprints separated by 14 days.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (N=16) performed a single bout of the same sprint protocol.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Repeated bout group (N=16)
Number of subjects: 32
Study: 25636253

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 50

Group type: COMPARATOR
Intervention: 90° side‐lying position
Number of subjects: 50

Group type: COMPARATOR
Intervention: 60° side‐lying position
Number of subjects: 50
Study: 23388114

Group type: EXPERIMENTAL
Intervention: Reciprocal peer support (RPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse care management
Number of subjects: 0
Study: 20620208

Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home exercise training
Number of subjects: 0
Study: 18423050

Group type: EXPERIMENTAL
Intervention: Interactive small group education program with locally adapted guidelines (Group 1)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Adapted guidelines only (Group 2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Unrelated education intervention (Group 3)
Number of subjects: 51
Study: 16622162

Group type: EXPERIMENTAL
Intervention: Computerized clinical decision support system
Number of subjects: 4507

Group type: COMPARATOR
Intervention: No computerized clinical decision support system (control)
Number of subjects: 4507
Study: 12531808

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Irradiation without G-CSF
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Irradiation plus G-CSF
Number of subjects: 412

Group type: COMPARATOR
Intervention: Neither irradiation nor G-CSF
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: G-CSF (excluding irradiation)
Number of subjects: 412
Study: 11049883

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8969721

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate infusion, 25 mg/kg (maximum, 2 gm) for 20 minutes
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (equivolume saline solution for 20 minutes)
Number of subjects: 31
Study: 8443401

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (Ag) 500 mg/day with hydrocortisone supplementation from 30 to 60 mg/day
Number of subjects: 257

Group type: COMPARATOR
Intervention: Oral medroxyprogesterone acetate (MPA) 500 mg twice a day
Number of subjects: 257
Study: 6391658

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy plus immunotherapy with PSK
Number of subjects: 73

Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 73
Study: 31241761

Group type: EXPERIMENTAL
Intervention: Simulator training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (live implant insertions)
Number of subjects: 50